NAVIDEA BIOPHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dublin, OH
SEC filing record 1 source field available
Fiscal year end
31 December
NAVIDEA BIOPHARMACEUTICALS, INC. has filed 1,465 SEC EDGAR filings since 07 Feb 1995

SEC filing history

Showing 401-425 of 949 matching filings.

Per page
25
Current page
17
8-K File 001-35076

FORM 8-K

Filing date
09 Aug 2017
Reporting date
08 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jul 2017
Reporting date
29 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Jun 2017
Reporting date
30 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Jun 2017
Reporting date
30 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Jun 2017
Reporting date
30 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Jun 2017
Reporting date
30 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
30 Jun 2017
Reporting date
29 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
29 Jun 2017
Reporting date
26 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 LATKIN

Filing date
31 May 2017
Reporting date
30 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SD File 001-35076

FORM SD

Filing date
31 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-35076

DEFINITIVE 14A

Filing date
24 May 2017
Reporting date
29 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 LATKIN

Filing date
23 May 2017
Reporting date
19 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 LATKIN

Filing date
19 May 2017
Reporting date
17 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 GOLDBERG

Filing date
16 May 2017
Reporting date
16 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
16 May 2017
Reporting date
12 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-217814

FORM S-8 REGISTRATION STATEMENT

Filing date
09 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
09 May 2017
Reporting date
09 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-35076

PRELIMINARY 14A

Filing date
08 May 2017
Reporting date
08 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 May 2017
Reporting date
04 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
01 May 2017
Reporting date
25 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-35076

NAVIDEA BIOPHARMACEUTICALS FORM 10-K

Filing date
31 Mar 2017
Reporting date
31 Dec 2016
Next action
Verify source filing
CT ORDER File 001-35076

CT ORDER filing

Filing date
27 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 001-35076

NOTIFICATION OF LATE FILING

Filing date
16 Mar 2017
Reporting date
31 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
13 Mar 2017
Reporting date
08 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .